Similarly, a prior study showed that low Fbxo22 expression shared correlation with worse survival in human breast cancer, and knockdown of Fbxo22 promoted breast cancer cell invasiveness (Bai et al. 2019). The gene discussed is FBXO22; the disease is breast carcinoma.